Locus-Specific Analysis of Human Leukocyte Antigen Class I Expression in Melanoma Cell Lines
Authors:
- Toni B. SimonisTSToni B. Simonis
- Andrea AbatiAAAndrea Abati
- Julia HackettJHJulia Hackett
- Teresita O'DeaTOTeresita O'Dea
- Patricia FetschPFPatricia Fetsch
- Nicholas P. RestifoNRNicholas P. Restifo
- 1 July 1994
- journal article
- basic scientific-studies
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 16 (1) , 13-23
Abstract
Summary Surface expression of human leukocyte antigen (HLA) class I antigens on melanoma lines was evaluated by locus-specific monoclonal antibodies (mAbs) with three different techniques: Fluorescence-activated cell sorting (FACS), immunohistochemistry with cytospin preparation (ICP), and complement- mediated cytotoxicity (CMC). Eleven HLA class I-expressing cell lines developed from metastases were used. Specific expression of HLA loci was examined under routine culture conditions and after 48-h incubation in interferon-γ (IFN-γ 500 U/ ml). Loss of allelic expression was seen in one line (586-MEL): Products of genes coding for HLA-A29 and -B44, in strong linkage disequilibrium, were not detectable. HLA-A antigens were consistently detected by all methodologies and minimally affected by pretreatment with IFN- γ. HLA-B antigens were detectable in 8 of 11 lines by ICP and 3 of 11 lines by CMC. By FACS the supratypic specificity HLA-Bw6 was expressed at low levels in most lines (mean fluorescence 47.2 ± 13.4 and rose to 259.8 ± 45.9 after incubation with IFN-γ p<0.001). HLA-Cw antigen detection by CMC correlated with HLA-B (p<0.01), suggesting that down-regulation and sensitivity to IFN-γ are shared by the two loci. This low expression of the HLA-B antigens may play a role in the evasion of the host immune response and its up-regulation may be useful in allowing tumor antigen recognition.Keywords
This publication has 39 references indexed in Scilit:
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformantsNature, 1988
- Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trialsJournal of Immunological Methods, 1987
- Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypesInternational Journal of Cancer, 1987
- Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanomaPathology, 1987
- A monoclonal antibody against HLA-A11 and A24Human Immunology, 1986
- Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell linesHuman Immunology, 1985
- A monoclonal antibody directed against the HLA-Bw6 epitope.The Journal of Immunology, 1982
- Monoclonal Antibody to HLA-A3Hybridoma, 1982
- HLA-A,B,C and DR Alloantigen Expression on Forty-Six Cultured Human Tumor Cell Lines2JNCI: Journal of the National Cancer Institute, 1981